Published in Semin Liver Dis on February 01, 2004
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut (2007) 3.58
Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol (2010) 2.25
Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. Hepatology (2008) 1.85
Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol (2007) 1.34
Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C. J Clin Pathol (2006) 1.21
Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol (2008) 1.13
Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. ISRN Gastroenterol (2011) 1.12
Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. World J Gastroenterol (2009) 1.02
Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched. Gut (2006) 1.02
Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures. Hepat Mon (2012) 1.00
Liver biopsies for chronic hepatitis C: should nonultrasound-guided biopsies be abandoned? Can J Gastroenterol (2009) 0.92
Chronic hepatitis C and liver fibrosis. World J Gastroenterol (2014) 0.92
Real-time elastography as a noninvasive technique for quantification of fibrosis in patients with chronic viral liver disease: Preliminary findings. J Ultrasound (2012) 0.89
Checkmate to liver biopsy in chronic hepatitis C? World J Gastroenterol (2012) 0.84
Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B. Gut Liver (2016) 0.81
Correlation of Laparoscopic Liver Biopsy to Elasticity Measurements (FibroScan) in Patients With Chronic Liver Disease. Gastroenterol Hepatol (N Y) (2008) 0.81
Computer-aided morphometry of liver inflammation in needle biopsies. World J Gastroenterol (2005) 0.80
Assessment of hepatic fibrosis regression by transient elastography in patients with chronic hepatitis B treated with oral antiviral agents. J Korean Med Sci (2014) 0.80
Is liver biopsy still needed in children with chronic viral hepatitis? World J Gastroenterol (2015) 0.78
Liver fibrosis: natural history may be affected by the biopsy sample. Gut (2004) 0.78
Influence of expert-dependent variability over the performance of noninvasive fibrosis assessment in patients with chronic hepatitis C by means of texture analysis. Comput Math Methods Med (2011) 0.78
ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study. J Ultrasound (2012) 0.77
Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C. World J Gastroenterol (2016) 0.75
HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication. BMC Gastroenterol (2014) 0.75
Deciding on Interferon-Free Treatment for Chronic Hepatitis C: Updating Liver Stiffness Cut-Off Values to Maximize Benefit. PLoS One (2016) 0.75
Transjugular liver biopsy: results of 97 patients. Balkan Med J (2012) 0.75
[Liver biopsy at the intersection of clinical and pathological diagnosis]. Pathologe (2008) 0.75
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol (2009) 3.29
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology (2004) 2.70
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell (2005) 2.66
Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology (2008) 2.63
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol (2008) 2.32
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol Immunother (2011) 2.16
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg (2004) 1.88
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine (2004) 1.65
Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol (2008) 1.62
Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. Clin Gastroenterol Hepatol (2010) 1.58
Barrett's epithelium after antireflux surgery. J Gastrointest Surg (2005) 1.52
Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointest Endosc (2007) 1.51
Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol (2012) 1.51
Definition of Barrett's esophagus dysplasia: are we speaking the same language? World J Surg (2015) 1.50
Liver steatosis in children with chronic hepatitis C. Am J Gastroenterol (2006) 1.46
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol (2012) 1.41
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med (2010) 1.40
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics (2013) 1.39
Staging gastritis: an international proposal. Gastroenterology (2005) 1.29
PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch (2011) 1.28
MicroRNA expression profiling of male breast cancer. Breast Cancer Res (2009) 1.22
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake. Clin Endocrinol (Oxf) (2007) 1.20
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol (2012) 1.18
Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl (2009) 1.18
MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer (2011) 1.17
Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol (2013) 1.15
The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation. J Biol Chem (2013) 1.14
Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol (2003) 1.12
Neck emergency due to parathyroid adenoma bleeding: a case report. J Med Case Rep (2009) 1.10
Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer (2012) 1.07
The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol (2006) 1.07
Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. Surgery (2010) 1.07
Hepatoid adenocarcinoma of the colon: what should we target? Pathol Oncol Res (2011) 1.05
Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev (2008) 1.02
Programmed cell death 4 protein in esophageal cancer. Oncol Rep (2010) 1.01
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Hum Pathol (2013) 1.00
Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. J Infect Dis (2011) 0.99
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem (2008) 0.99
Early HER2 dysregulation in gastric and oesophageal carcinogenesis. Histopathology (2012) 0.98
The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation. J Clin Invest (2013) 0.96
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. Hepatology (2011) 0.96
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. Thyroid (2011) 0.96
MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. Thyroid (2012) 0.96
Autoimmune atrophic gastritis--pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol (2013) 0.96
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. Eur J Endocrinol (2011) 0.95
Anterior gradient 2 overexpression in lung adenocarcinoma. Appl Immunohistochem Mol Morphol (2012) 0.95
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. Blood (2011) 0.94
Rectal cancer neoadjuvant treatment in elderly patients. Anticancer Res (2006) 0.94
PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. Virchows Arch (2012) 0.93
Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer? Helicobacter (2003) 0.93
Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Ann Surg Oncol (2011) 0.93
Pathogenesis of Helicobacter pylori infection. Helicobacter (2012) 0.92
Hepatic spleen nodules (HSN). Scand J Gastroenterol (2010) 0.92
Re: CDX2 homeotic gene expression in gastric noninvasive neoplasia. Am J Surg Pathol (2004) 0.91
Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol (2004) 0.91
microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6. Gut (2012) 0.91
Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis. World J Gastroenterol (2006) 0.91
Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. Int J Cancer (2008) 0.91
Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters. Scand J Gastroenterol (2007) 0.89
BRAF in primary and recurrent papillary thyroid cancers: the relationship with (131)I and 2-[(18)F]fluoro-2-deoxy-D-glucose uptake ability. Eur J Endocrinol (2010) 0.89
Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci (2006) 0.89
Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. J Clin Pathol (2010) 0.88
The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples. Transl Oncol (2013) 0.88
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. Endocr Connect (2013) 0.88
CDX2 hox gene product in a rat model of esophageal cancer. J Exp Clin Cancer Res (2009) 0.88
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy. Oncotarget (2013) 0.88
Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol (2010) 0.86
Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett's esophagus. Cancer Causes Control (2013) 0.86
Primary squamous cell carcinoma of the thyroid: immunohistochemical profile and literature review. Tumori (2007) 0.86
miRNAs in precancerous lesions of the gastrointestinal tract. World J Gastroenterol (2011) 0.86
Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol (2012) 0.86
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years' endoscopical survey. World J Gastroenterol (2006) 0.85
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. Virchows Arch (2014) 0.85
5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results. Arch Med Res (2006) 0.85
Comparison of the diagnostic accuracy of combined elastosonography and BRAF analysis vs cytology and ultrasonography for thyroid nodule suspected of malignancy. Clin Endocrinol (Oxf) (2012) 0.84
Role of genotyping in non-small cell lung cancer treatment: current status. Drugs (2011) 0.84
Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas. Hum Pathol (2012) 0.84
Trifluoroacetylated proteins in liver and plasma of guinea pigs treated with HCFC-123 and halothane. Toxicol Lett (2003) 0.84
Oxidative DNA damage in Barrett mucosa: correlation with telomeric dysfunction and p53 mutation. Ann Surg Oncol (2013) 0.83
Magnetic resonance enterography for Crohn's disease: what the surgeon can take home. J Gastrointest Surg (2011) 0.82
Non-invasive diagnosis of Helicobacter pylori infection: simplified 13C-urea breath test, stool antigen testing, or DNA PCR in human feces in a clinical laboratory setting? Clin Biochem (2004) 0.82
Assessing risks for gastric cancer: new tools for pathologists. World J Gastroenterol (2006) 0.82
Helicobacter pylori infection in children and adults: a single pathogen but a different pathology. Helicobacter (2003) 0.82
Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype. J Clin Pathol (2007) 0.82
Apert syndrome with fused thalami. Fetal Pediatr Pathol (2012) 0.81
Neoangiogenesis in temporal bone carcinoma: the prognostic role of CD105. Otol Neurotol (2012) 0.81
Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia. Hum Pathol (2009) 0.81
Helicobacter pylori Infection, Intestinal Metaplasia, and Gastric Cancer Risk in Eastern Siberia. Helicobacter (2011) 0.81
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. Clin Chim Acta (2007) 0.81
Secondary prevention of epidemic gastric cancer in the model of Helicobacter pylori-associated gastritis. Dig Dis (2014) 0.81
Natural course of functional dyspepsia after Helicobacter pylori eradication: a seven-year survey. Dig Dis Sci (2005) 0.81
Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells. PLoS One (2011) 0.81
Wilson disease: histopathological correlations with treatment on follow-up liver biopsies. World J Gastroenterol (2010) 0.81
Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy. J Gastrointest Surg (2011) 0.81
Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol (2013) 0.81
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. Clin Chim Acta (2011) 0.80
Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas. Cancer Sci (2009) 0.80
Trefoil peptides, E-cadherin, and beta-catenin expression in sporadic fundic gland polyps: further evidence toward the benign nature of these lesions. Appl Immunohistochem Mol Morphol (2009) 0.80
Esophageal GIST: case report of surgical enucleation and update on current diagnostic and therapeutic options. Int J Surg Pathol (2007) 0.80